Comparative analysis of preventive role of different probiotics and prebiotics against the markers of liver damage, oxidative stress markers and inflammatory markers in the non-alcoholic fatty liver disease induced rats

References

• Asrani, S. K.; Devarbhavi, H.; Eaton, J.; Kamath, P. S. Burden of Liver Diseases in the World. J. Hepatol. 2019, 70(1), 151–171. DOI: 10.1016/j.jhep.2018.09.014.
   PubMed Web of Science ®Google Scholar
• Ando, Y.; Jou, J. H. Nonalcoholic Fatty Liver Disease and Recent Guideline Updates. Clin. Liver Dis. 2021, 17(1), 23. DOI: 10.1002/cld.1045.
   Google Scholar
• Wong, W. K.; Chan, W. K. Nonalcoholic Fatty Liver Disease: A Global Perspective. Clin. Ther. 2021, 43(3), 473–499. DOI: 10.1016/j.clinthera.2021.01.007.
   PubMed Web of Science ®Google Scholar
• Powell, E. E.; Wong, V. W. S.; Rinella, M. Non-alcoholic Fatty Liver Disease. Lancet. 2021, 397(10290), 2212–2224. DOI: 10.1016/S0140-6736(20)32511-3.
   PubMed Web of Science ®Google Scholar
• Loomba, R.; Friedman, S. L.; Shulman, G. I. Mechanisms and Disease Consequences of Nonalcoholic Fatty Liver Disease. Cell. 2021, 184(10), 2537–2564. DOI: 10.1016/j.cell.2021.04.015.
   PubMed Web of Science ®Google Scholar
• Muthiah, M. D.; Cheng Han, N.; Sanyal, A. J. A Clinical Overview of Non‐alcoholic Fatty Liver Disease: A Guide to Diagnosis, the Clinical Features, and complications—what the Non‐specialist Needs to Know. Diabetes Obes. Metab. 2022, 24(S2), 3–14. DOI: 10.1111/dom.14521.
   PubMedGoogle Scholar
• Chang, E.; Park, C. Y.; Park, S. W. Role of Thiazolidinediones, Insulin Sensitizers, in Non‐alcoholic Fatty Liver Disease. J. Diabetes Investig. 2013, 4(6), 517–524. DOI: 10.1111/jdi.12107.
   PubMed Web of Science ®Google Scholar
• Marceau, P.; Biron, S.; Hould, F. S.; Marceau, S.; Simard, S.; Thung, S. N.; Kral, J. G. Liver Pathology and the Metabolic Syndrome X in Severe Obesity. J. Clin. Endocrinol. Metab. 1999, 84(5), 1513–1517. DOI: 10.1210/jcem.84.5.5661.
   PubMed Web of Science ®Google Scholar
• Negi, C. K.; Babica, P.; Bajard, L.; Bienertova-Vasku, J.; Tarantino, G. Insights into the Molecular Targets and Emerging Pharmacotherapeutic Interventions for Nonalcoholic Fatty Liver Disease. Metabolism. 2022, 126, 154925. DOI: 10.1016/j.metabol.2021.154925.
   PubMed Web of Science ®Google Scholar
• Cunningham, M.; Azcarate-Peril, M. A.; Barnard, A.; Benoit, V.; Grimaldi, R.; Guyonnet, D.; Holscher, H. D.; Hunter, K.; Manurung, S.; Obis, D., et al. Shaping the Future of Probiotics and Prebiotics. Trends Microbiol. 2021, 29(8), 667–685. DOI: 10.1016/j.tim.2021.01.003.
   PubMed Web of Science ®Google Scholar
• Montrose, D. C.; Floch, M. H. Probiotics Used in Human Studies. J. Clin. Gastroenterol. 2005, 39(6), 469–484. DOI: 10.1097/01.mcg.0000165649.32371.71.
   PubMed Web of Science ®Google Scholar
• Gupta, V.; Garg, R. Probiotics. Indian J. Med. Microbiol. 2009, 27(3), 202–209. DOI: 10.4103/0255-0857.53201.
   PubMed Web of Science ®Google Scholar
• Wu, H.; Chiou, J. Potential Benefits of Probiotics and Prebiotics for Coronary Heart Disease and Stroke. Nutrients. 2021, 13(8), 2878. DOI: 10.3390/nu13082878.
   PubMed Web of Science ®Google Scholar
• Lim, C. C.; Ferguson, L. R.; Tannock, G. W. Dietary Fibres as “Prebiotics”: Implications for Colorectal Cancer. Mol. Nutr. Food Res. 2005, 49(6), 609–619. DOI: 10.1002/mnfr.200500015.
   PubMed Web of Science ®Google Scholar
• Roberfroid, M. Prebiotics: The Concept Revisited. ‎J. Nutr. 2007, 137(3), 830S–837S. DOI: 10.1093/jn/137.3.830S.
   PubMed Web of Science ®Google Scholar
• Ashwell, M. Concepts of Functional Foods. ILSI Europe Concise Monograph Series. Nutr. Food Sci. 2004, 34(1), 47–47. https://doi.org/10.1108/nfs.2004.34.1.47.3
   Google Scholar
• Saavedra, J. M.; Tschernia, A. Human Studies with Probiotics and Prebiotics: Clinical Implications. Br. J. Nutr. 2002, 87(S2), S241–S246. DOI: 10.1079/BJN/2002543.
   PubMedGoogle Scholar
• Sekhon, B. S.; Jairath, S. Prebiotics, Probiotics and Synbiotics: An Overview. J. Pharm. Sci. Res. 2010, 1(2), 13–36.
   Google Scholar
• Lasker, S.; Rahman, M. M.; Parvez, F.; Zamila, M.; Miah, P.; Nahar, K.; Kabir, F.; Sharmin, S. B.; Subhan, N.; Ahsan, G. U., et al. High-fat diet-induced Metabolic Syndrome and Oxidative Stress in Obese Rats are Ameliorated by Yogurt Supplementation. Sci. Rep. 2019, 9(1), 1–15. DOI: 10.1038/s41598-019-56538-0.
   PubMedGoogle Scholar
• Bancroft, J. D., and Gamble, M., Eds. Theory and Practice of Histological Techniques; China: Elsevier health sciences, 2008.
   Google Scholar
• Wills, E. Mechanisms of Lipid Peroxide Formation in Animal Tissues. Biochem. J. 1966, 99(3), 667–676. DOI: 10.1042/bj0990667.
   PubMed Web of Science ®Google Scholar
• Dieterich, S.; Bieligk, U.; Beulich, K.; Hasenfuss, G.; Prestle, J. Gene Expression of Antioxidative Enzymes in the Human Heart: Increased Expression of Catalase in the end-stage Failing Heart. Circulation. 2000, 101(1), 33–39. DOI: 10.1161/01.CIR.101.1.33.
   PubMed Web of Science ®Google Scholar
• Jollow, D. J.; Mitchell, J. R.; Zampaglione, N.; Gillette, J. R. Bromobenzene-induced Liver Necrosis. Protective Role of Glutathione and Evidence for 3, 4-bromobenzene Oxide as the Hepatotoxic Metabolite. Pharmacol. 1974, 11(3), 151–169. DOI: 10.1159/000136485.
   PubMed Web of Science ®Google Scholar
• Steel, R. G.; Dickey, J. H. Pinciples and Procedures of Statistics a Biometrical Approach, 1997, (No. 519.5 S8).
   Google Scholar
• de Clercq, N. C.; Groen, A. K.; Romijn, J. A.; Nieuwdorp, M. Gut Microbiota in Obesity and Undernutrition. Adv. Nutr. 2016, 7(6), 1080–1089. DOI: 10.3945/an.116.012914.
   PubMed Web of Science ®Google Scholar
• Slavin, J. Fiber and Prebiotics: Mechanisms and Health Benefits. Nutrients. 2013, 5(4), 1417–1435. DOI: 10.3390/nu5041417.
   PubMed Web of Science ®Google Scholar
• Famouri, F.; Shariat, Z.; Hashemipour, M.; Keikha, M.; Kelishadi, R. Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents. J. Pediatr. Gastroenterol. Nutr. 2017, 64(3), 413–417. DOI: 10.1097/MPG.0000000000001422.
   PubMed Web of Science ®Google Scholar
• Asgharian, A.; Mohammadi, V.; Gholi, Z.; Esmaillzadeh, A.; Feizi, A.; Askari, G. 2017. The Effect of Synbiotic Supplementation on Body Composition and Lipid Profile in Patients with NAFLD: A Randomized, Double Blind, placebo-controlled Clinical Trial Study. Iran. Red. Crescent. Med. J 19(4) DOI: 10.5812/ircmj.42902.
   Web of Science ®Google Scholar
• Tagliari, E.; Campos, A. C.; Costa-Casagrande, T. A.; Salvalaggio, P. R. The Impact of the Use of Symbiotics in the Progression of Nonalcoholic Fatty Liver Disease in a Rat Model. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 2017, 30(3), 211–215. DOI: 10.1590/0102-6720201700030011.
   Google Scholar
• Çakır, M.; İşbilen, A. A.; Eyüpoğlu, İ.; Sağ, E.; Örem, A.; Şen, T. M.; Kaklıkkaya, N.; Gjtjg, K. Effects of long-term Synbiotic Supplementation in Addition to Lifestyle Changes in Children with obesity-related non-alcoholic Fatty Liver Disease. Turkish j. gastroenterol: official j. Turkish Soci Gastroenterol. 2017, 28(5), 377–383. DOI: 10.5152/tjg.2017.17084.
   PubMed Web of Science ®Google Scholar
• Kobyliak, N.; Abenavoli, L.; Falalyeyeva, T.; TJAoh, B. Efficacy of Probiotics and Smectite in Rats with non-alcoholic Fatty Liver Disease. J. Hepatol. 2018, 17(1), 153–161.
   Google Scholar
• Monem, S. M. A. Probiotic Therapy in Patients with Nonalcoholic Steatohepatitis in Zagazig University Hospitals. Euroasian j. hepato-gastroenterol. 2017, 7(1), 101. DOI: 10.5005/jp-journals-10018-1226.
   PubMedGoogle Scholar
• Manzhalii, E.; Virchenko, O.; Falalyeyeva, T.; Beregova, T.; WJJodd, S. Treatment Efficacy of A Probiotic Preparation for Non‐alcoholic Steatohepatitis: A Pilot Trial. J.digestive dis. 2017, 18(12), 698–703. DOI: 10.1111/1751-2980.12561.
   PubMed Web of Science ®Google Scholar
• Perumpail, B. J.; Li, A. A.; John, N.; Sallam, S.; Shah, N. D.; Kwong, W.; Cholankeril, G.; Kim, D.; Ahmed, A. J. D. The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD. Diseases. 2019, 7(1), 27.
   Google Scholar
• Mofidi, F.; Poustchi, H.; Yari, Z.; Nourinayyer, B.; Merat, S.; Sharafkhah, M.; Hekmatdoost, A.; Hekmatdoost, A. Synbiotic Supplementation in Lean Patients with non-alcoholic Fatty Liver Disease: A Pilot, Randomised, double-blind, placebo-controlled, Clinical Trial. Br. J. Nutr. 2017, 117(5), 662–668. DOI: 10.1017/S0007114517000204.
   PubMed Web of Science ®Google Scholar
• Cui, Y.; Wang, Q.; Chang, R.; Zhou, X.; CJJoa, X.; chemistry, F. Intestinal Barrier Function–Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota. J. agric. food chem. 2019, 67(10), 2754–2762. DOI: 10.1021/acs.jafc.9b00080.
   PubMed Web of Science ®Google Scholar
• Ekhlasi, G.; Zarrati, M.; Agah, S.; Hosseini, A. F.; Hosseini, S.; Shidfar, S.; Aarbshahi, S. S. S.; Razmpoosh, E.; FJEj, S. Effects of Symbiotic and Vitamin E Supplementation on Blood Pressure, Nitric Oxide and Inflammatory Factors in non-alcoholic Fatty Liver Disease. EXCLI j. 2017, 16, 278. DOI: 10.17179/excli2016-846.
   PubMed Web of Science ®Google Scholar